Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Therapeutic drug monitoring of beta-lactam and fluoroquinolone antibiotics in ICU patients
NL-OMON21680Not yet recruiting
- Sponsor
- Erasmus MC
- Start
- Sep 2018
- Countries
- 1
01
Overview
Open-label trial in bacterial disease, sponsored by Erasmus MC. Planned start Sep 2018; status: not yet recruiting.
02
Conditions
bacterial disease
Beyond the preview
Go deeper on NL-OMON21680.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON21680.